X Chromosome p22.33 Microdeletion: Implications for Genetic Testing - Obstetrics and Gynecology

Share to:

The X chromosome region p22.33 contains a 0.47 Mb segmental duplication?


Hello, I underwent amniocentesis and amniotic fluid chromosomal microarray analysis at 20 weeks, and the report indicated a 0.47 Mb microdeletion in the X chromosome region p22.33.
The hospital conducted blood tests on me and my husband, and the results confirmed that the fetus and both parents underwent MLPA-P018-G2 analysis, which showed that the SHOX gene on the X chromosome has a duplication inherited from my husband.
Since it is inherited from my husband, I would like to inquire about the MLPA analysis results: "MLPA Analysis: rsa[GRCh36] Xp22.33(318975_729321)x3" for the fetus, and "rsa[GRCh36] Xp22.33(318975_729321)x2" for my husband.
Is there a significant difference between x3 and x2? What symptoms might be associated with this condition?

Xiao Ke, 30~39 year old female. Ask Date: 2021/01/26

Dr. Cao Guotao reply Obstetrics and Gynecology


Hello, I'm sorry, but I'm not an expert in this area.
You may consult the physician who assisted you.
Wishing you good health.

Reply Date: 2021/01/26

More Info


Understanding the implications of an X chromosome p22.33 microdeletion or duplication, particularly in the context of genetic testing, is crucial for anticipating potential health outcomes for both the fetus and the parents. The findings from your amniocentesis and subsequent genetic testing indicate that there is a duplication of the SHOX gene located in the p22.33 region of the X chromosome, which has been inherited from your husband.


Genetic Background
The SHOX gene (Short Stature Homeobox) is essential for normal skeletal development. Mutations or alterations in this gene can lead to various growth disorders, including Léri-Weill dyschondrosteosis and Turner syndrome, both of which can result in short stature and skeletal abnormalities. The significance of the duplication you mentioned (0.47Mb) suggests that there may be an increased dosage of the SHOX gene, which could potentially lead to phenotypic manifestations, although the exact effects can vary widely.


Implications of the Findings
1. Inheritance Patterns: Since the duplication is inherited from your husband, it is important to consider his family history and any potential symptoms he may have experienced. While many individuals with SHOX gene duplications may be asymptomatic, others may exhibit signs of growth disorders.

2. Potential Symptoms: The symptoms associated with SHOX gene duplications can include:
- Short stature
- Skeletal abnormalities (e.g., mesomelic dysplasia)
- Possible developmental delays or learning difficulties, although these are less common.

3. MLPA Analysis: The difference in the results of the MLPA analysis between you and your husband (x3 for the fetus and x2 for your husband) indicates that the fetus has three copies of the SHOX gene in that region, while your husband has two. This difference could suggest a potential for increased expression of the gene in the fetus, which may or may not lead to clinical manifestations. The clinical significance of having three copies versus two is not straightforward and often requires further clinical correlation and monitoring.


Recommendations
1. Genetic Counseling: It is highly advisable to seek genetic counseling. A genetic counselor can provide detailed information about the implications of the findings, discuss potential outcomes, and help you understand the risks and benefits of further testing or monitoring.

2. Monitoring and Follow-Up: Regular follow-up with pediatric specialists after birth may be warranted to monitor growth and development. Early intervention can be beneficial if any growth-related issues are identified.

3. Family Planning: Understanding the inheritance pattern can also inform future family planning decisions. If there are concerns about the potential for similar genetic findings in future pregnancies, preconception counseling may be beneficial.

4. Further Testing: Depending on the clinical context, additional testing may be recommended to assess for any associated conditions or to clarify the implications of the gene duplication.


Conclusion
In summary, the findings from your genetic testing indicate a duplication of the SHOX gene inherited from your husband, which may have implications for the growth and development of your child. While the exact clinical significance of the x3 versus x2 findings requires careful interpretation, it is crucial to engage with healthcare professionals who specialize in genetics for comprehensive guidance and support. Regular monitoring and early intervention can play a significant role in managing any potential health issues that may arise.

Similar Q&A

Understanding the Impact of Chromosome 15q11.2 Microdeletions on Rare Diseases

The deletion at 138275 is located at the long arm of chromosome 15, specifically at q11.2, within the region from 22,770,421 to 23,282,798, which corresponds to OMIM (615656). What potential impacts could this have? The blood test has confirmed it is hereditary, but the mother is...


Dr. Chen Ming reply Rare Disease
Please scan your report and send it to [email protected]. Additionally, call 04-7238595 ext. 7244 to request assistance from a genetic counselor to add me to the Chang Gung Memorial Hospital outpatient clinic. God bless you. [The case results do not specify the genome version...

[Read More] Understanding the Impact of Chromosome 15q11.2 Microdeletions on Rare Diseases


Understanding Chromosomal Deletions: Impacts of 9p24.3p24.2 on Health

Hello Doctor, the results of the amniocentesis genetic testing indicate that the sample consists of female components with X chromosome sequences. However, there is a deletion of a 2.34 Mb microdeletion in the short arm of chromosome 9 at the p24.3p24.2 region. This may also repr...


Dr. Chen Ming reply Rare Disease
You can consult a renowned obstetrician in the area, or call 04-7238595 extension 7244 to schedule an appointment.

[Read More] Understanding Chromosomal Deletions: Impacts of 9p24.3p24.2 on Health


Understanding the Implications of 7q34-36.3 Chromosome Deletion in Pregnancy

Hello, doctor. I am currently 21 weeks pregnant. I have undergone two NIPT blood tests, which indicated a 20mb deletion at chromosome 7q34-36.3. I am now waiting for the results of the aCGH microarray analysis. I would like to ask: (1) What potential conditions could arise from t...


Dr. Chen Ming reply Rare Disease
The peace of mind comes from the fact that this is a highly complex and difficult test. We must wait for the results of the ACGH chip before we can explain everything in person. God bless!

[Read More] Understanding the Implications of 7q34-36.3 Chromosome Deletion in Pregnancy


Understanding 16p13.3 Microduplication: Implications for Fetal Health

Hello Doctor, I am a 30-year-old first-time mother who is 20 weeks pregnant. I have Graves' disease, which is well-controlled with medication. I have had intermittent mild microcytic anemia in the past, and my doctor has suspected either thalassemia or iron deficiency anemia...


Dr. Jian Yingxiu reply Rare Disease
Hello: Anticipating new life yet encountering such uncertainty can indeed be unsettling. It seems you have already gathered all the information, but due to incomplete penetrance, even if one parent has similar chromosomal variations, there is still a chance that the baby may expe...

[Read More] Understanding 16p13.3 Microduplication: Implications for Fetal Health


Related FAQ

Down Syndrome

(Obstetrics and Gynecology)

Genitals

(Obstetrics and Gynecology)

Polycystic Ovary Syndrome

(Obstetrics and Gynecology)

Pid

(Obstetrics and Gynecology)

Endometrial Abnormalities

(Obstetrics and Gynecology)

Conception

(Obstetrics and Gynecology)

Cervical Intraepithelial Neoplasia

(Obstetrics and Gynecology)

Adenomyosis

(Obstetrics and Gynecology)

Neural Tube Defects

(Obstetrics and Gynecology)

Spontaneous Miscarriage

(Obstetrics and Gynecology)